During the past decade, Urology South Shore Research conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Urology South Shore Research" #1 sponsor was "Pfizer" with 4 trials, followed by "CMX Research" with 2 trials sponsored, "AEterna Zentaris" with 1 trials sponsored, "Bayer" with 1 trials sponsored and "Ferring Pharmaceuticals" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Urology South Shore Research" #1 collaborator was "Astellas Pharma Inc" with 3 trials as a collaborator, "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Ferring Pharmaceuticals" with 1 trials as a collaborator and "GlaxoSmithKline" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Urology South Shore Research" are "Prostate Cancer" (7 trials), "Cancer of the Prostate" (2 trials), "Benign Prostatic Hyperplasia" (1 trials), "Benign Prostatic Hypertrophy" (1 trials) and "Erectile Dysfunction" (1 trials). Many other conditions were trialed in "Urology South Shore Research" in a lesser frequency.

Most popular intervention types in "Urology South Shore Research" are "Drug" (8 trials), "Dietary Supplement" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Enzalutamide" (2 trials), "Cetrorelix 78 mg + 52 mg" (1 trials), "Cetrorelix 78 mg + 78 mg" (1 trials) and "Combination of 2007RD01 and saw palmetto lipidic extract" (1 trials). Other intervention names were less common.

The vast majority of trials in "Urology South Shore Research" are 10 trials for "Male" genders, 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Urology South Shore Research". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Urology South Shore Research, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Urology South Shore Research, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".